Successful Field Trials

The performance of the Rapid Biosensor Systems TB Breathalyser has been validated in a series of field trials with over just under 1000 patients within five different a hospital environments, as part of five different trials.

The system successfully passed completely independent trials in Ethiopia under the supervision of the London School of Hygiene and Tropical Medicine see:

Our most recent trials were conducted successfully on pre-production beta prototypes at the Ayder Hospital, Mekelle University, Ethiopia, where tests were carried out in 3-centres, the Ayder Referral Hospital, Mekelle & Wukro Hospitals in 2012-13. The results showed sensitivities and specificities of >95% for early stage actively infectious patients.